Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Auren Rx vs Rylo Health

Auren Rx
Graded #79

Higher grade

vs+8.2
Rylo Health
Graded #247

Lower grade

The verdict

Auren Rx takes it — 72.9/100 to 64.7/100.

Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAuren Rx +10
74
64
Dose & formulationEven
64
64
Clinical oversightAuren Rx +8
83
75
Labs & monitoringEven
53
53
FulfillmentAuren Rx +14
97
83
Contract termsAuren Rx +30
67
37
Auren Rx · left barRylo Health · right bar

The numbers

MetricAuren RxRylo Health
WeighScore72.9/10064.7/100
GradeCC
Scorecard rank#79#247
Semaglutide$149/mo (auto-refill; a single month with no commitment is $179)$149/mo (promotional rate, compounded)
Tirzepatide$149/mo (auto-refill; a single month with no commitment is $179)$249/mo (compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Auren Rx

Graded #79 · C

Strengths

  • Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
  • A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
  • Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
  • Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern

Where it loses points

  • The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
  • Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
  • Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
  • The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
  • No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
  • NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Rylo Health

Graded #247 · C

Strengths

  • Names its dispensing pharmacy in full, with address and phone: VialsRX in Houston, Texas
  • Names its medical group, Lone Star Virtual Health PLLC, and gives a provider contact
  • Standard prices published openly alongside the promotional rate, so the real ongoing cost is visible
  • Cancel in one click from the patient portal, with no contracts and no cancellation fees
  • Peptide line priced openly, including NAD+ and sermorelin

Where it loses points

  • Headline $100 and $160 rates are limited to the first 20 patients; standard rates are $149 and $249
  • No LegitScript certification is claimed or displayed
  • Several peptide products are advertised as coming soon rather than available
  • No published refund policy beyond the no-cancellation-fee statement

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard